Cas:1181574-74-2 2-(2-Fluorophenyl)-3-methylbutanoic acid manufacturer & supplier

Chemical Name:2-(2-Fluorophenyl)-3-methylbutanoic acid

CAS.NO:1181574-74-2

Synonyms:2-(2-Fluorophenyl)-3-methylbutanoic acid

Molecular Formula:C₁₁H₁₃FO₂

Molecular Weight:196.21800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:37.30000

Exact Mass:196.09000

LogP:2.64990

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(2-Fluorophenyl)-3-methylbutanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-Fluorophenyl)-3-methylbutanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-Fluorophenyl)-3-methylbutanoic acid Use and application,2-(2-Fluorophenyl)-3-methylbutanoic acid technical grade,usp/ep/jp grade.

Related News: Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 2-(2-Fluorophenyl)-3-methylbutanoic acid manufacturer Advanced clinical trials with the Company��s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS. 2-(2-Fluorophenyl)-3-methylbutanoic acid supplier The move follows a Class I recall, the FDA’s most serious, launched by Innova in late April amid “significant concerns” about the test’s accuracy—and alongside an official warning letter delivered to the company this week. 2-(2-Fluorophenyl)-3-methylbutanoic acid vendor Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 2-(2-Fluorophenyl)-3-methylbutanoic acid factory Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.